Notice of NHLBI Participation in PAR-18-901 "Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN) (D43 Clinical Trial Optional)"
Notice Number:
NOT-HL-20-807

Key Dates

Release Date:

August 21, 2020

Related Announcements

PAR-18-901

Issued by

National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The purpose of this Notice is to inform potential applicants that the National Heart, Lung, and Blood Institute (NHLBI) is participating, effective immediately, in Funding Opportunity Announcement (FOA) PAR-18-901 "Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN) (D43 Clinical Trial Optional)".

The following sections of PAR-18-901 have been updated to reflect the participation of NHLBI in this FOA.

Part 1. Overview Information

The following information has been added:

Components of Participating Organizations
Fogarty International Center (FIC)
National Institute of Environmental Health Sciences (NIEHS)
National Institute of Mental Health (NIMH)
National Institute of Neurological Disorders and Stroke (NINDS)
National Center for Complementary and Integrative Health (NCCIH)
National Institute on Aging (NIA)
National Institute on Dental and Craniofacial Research (NIDCR)
National Institute on Drug Abuse (NIDA)
National Heart, Lung, and Blood Institute (NHLBI)

Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.989, 93.853, 93.242, 93.213,93.279 93.113, 93.866, 93.121, 93.837, 93.838, 93.939, 93.840, 93.233

Part 2. Section I. Funding Opportunity Description

The following information has been added:

NIH IC Partner Interests

The National Heart, Lung, and Blood Institute (NHLBI) is interested in training programs that sustainably strengthen heart, lung, blood, and sleep (HLBS) research capacity of low- and middle-income country institutions; train in-country experts to develop and conduct research on HLBS diseases and disorders across the lifespan; and maximize NHLBI’s current global health investments, with the long-range goal of developing and implementing evidence-based, contextualized HLBS interventions to reduce the burden of chronic diseases. Examples of HLBS diseases and disorders include, but are not limited to, hypertension, obesity, rheumatic heart disease, chronic obstructive lung diseases, asthma, and sickle cell disease. Training programs across the spectrum of research disciplines are encouraged, from basic biomedical, behavioral, and social science to clinical and applied sciences, including translational and implementation science that emphasizes the resources, context, and needs of multiple stakeholders in local settings. Training programs should include research skills, research design and methodology, ethics, data management and analysis, grant writing, manuscript writing, scientific presentations and research administration.

Section VII. Agency Contacts

The following contacts have been added:

Scientific/Research Contacts

Makeda Williams, PhD, MPH
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-496-1051
Email:willimak@mail.nih.gov

Financial/Grants Management

Ryan Lombardi
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-827-8042
Email:lombardr@nhlbi.nih.gov

All other aspects of this FOA remain the same.

Inquiries

Please direct all inquiries to:

Makeda Williams, PhD, MPH
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-496-1051
Email:willimak@mail.nih.gov


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices